Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.

@article{Cheng2012GadoliniumchitosanNA,
  title={Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.},
  author={Jie-Jun Cheng and Jun Zhu and Xiao-Sheng Liu and Dan-Nong He and Jianrong Xu and Lian-Ming Wu and Juan Zhou and Qi Feng},
  journal={Acta radiologica},
  year={2012},
  volume={53 8},
  pages={900-7}
}
BACKGROUND MRI is of increasing importance in the diagnostic evaluation of gastrointestinal diseases, with depiction of mucosal enhancement obtained with conventional intravenous contrast. Routine clinical use of contrast agents has been carried out using intravenous injection for mucosal imaging. Contrast agents that specifically target the intestinal… CONTINUE READING